Fundraising Fox

Trase

2 known investors

Trase builds AI systems with built-in governance and auditability for organizations in high-stakes domains such as defense, healthcare, and critical infrastructure. The platform is designed to be secure by design and engineered for reliable performance in mission-critical applications.

Also known as Trase Origin Β· Trase OS

Founders & leadership

JLJoe Laws
Joe LawsinCo-Founder

Investors Β· 2

Funding

SEC filings, press & company announcements

$214M disclosed across 2 rounds Β· 2026

Source: company announcements and press reports β€” follow each round's link for the claim.

Company profile

researched Aug 2026

Trase is a McLean, Virginia-based company that develops a full-stack agentic AI platform for high-stakes, regulated environments including healthcare, defense/government and regulated enterprises. Its stack has three main components: Trase Origin, an operating system used to orchestrate, secure and govern AI agents across cloud, on-premises and edge deployments; Trase Leagues, a marketplace of pre-built, configurable agents; and Trase Arena, an SDK for building and launching custom agents on Trase OS. The company describes the platform as HIPAA and SOC 2 compliant, supporting unified policy enforcement, continuous monitoring, immutable audit trails, reinforcement learning from human feedback, and a judgment layer that routes certain decisions to humans.

Packaged agent workflows advertised by the company include nurse rostering, contract intelligence, policy enforcement, insurance verification, program risk evaluation, audit trail, claims scrubbing, public comments, prior authorization, denials management, statute research, credentialing, acquisition oversight, patient intake and referral management. Trase also develops edge-deployed specialized language models so customers can run agents where their data resides rather than moving data to a vendor environment. Deployment is presented as a four-step process β€” connecting existing systems, selecting or building agents, defining governance policies and approvals, and launching β€” with a stated target of production use in under 30 days.

The company was co-founded by Grant Verstandig (CEO) and Joe Laws (Chief Architect), and is associated with venture studio/investor Red Cell Partners. Leadership includes President Baskar Sridharan, CTO Srirama Koneru (a former AWS Bedrock general manager who joined in November 2025), CPO Michael Kilberry, CMO Katie Griff, CFO Barrett Yates-Mack, CMO (medical) Harry Phillips, MD, General Counsel Andrew Ngo and Chief Growth Officer Naimish Patel, plus national security advisors including former Secretary of Defense Mark T. Esper, George Barnes and Veronica Daigle.

Founding story

Trase was co-founded by Grant Verstandig, who serves as CEO, and Joe Laws, Chief Architect. The company is affiliated with Red Cell Partners, which lists Trase among its companies and handles its press contact.

Business model

Trase sells an AI agent operating system and a catalog of pre-built, configurable agents to enterprise and government customers, plus an SDK for customers to build their own agents on the platform. Deployments can run in customer cloud, on-premises or edge environments so that customer data remains under customer control. Sources do not disclose pricing or contract structures.

Not disclosed in the available sources; the company markets an agent marketplace, an operating system and an SDK to enterprise, health system and government buyers.

Traction

Company-reported benchmarks across deployed workflows cite production go-live in under 30 days, 99.8% administrative work reduction and more than $25M in annualized value creation. At Duke University Health System's Division of Cardiology, Trase agents automate routing of over 5,000 monthly faxes; initial observations reported fax triage 7.1x faster than manual processing, roughly 1,395 staff hours saved per month and about $285,450 in annual staff capacity unlocked, with peer-reviewed research described as forthcoming. Headcount reached 55 as of June 2026.

Latest developments

In June 2026 Trase closed a $107M seed round led by ARCH Venture Partners with participation from Red Cell Partners, to be used to expand its go-to-market team and continue building Trase Origin; one report also cites plans for strategic tuck-in acquisitions in agentic AI. Through July and August 2026 the company published material on its Duke Health deployment, defense AI governance and data sovereignty, and continued hiring across engineering, product and sales.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

Positioned as an AI infrastructure and agent provider for regulated industries where governance, security, sovereignty and predictability are prerequisites. Backer Red Cell Partners frames the opportunity around failure rates of enterprise generative AI pilots and constrained IT capacity in regulated sectors. The company reported topping the GAIA leaderboard for general AI assistants in September 2024 and again claiming the top spot on a Hugging Face leaderboard in February 2025.

Emphasis on governance, auditability and data sovereignty as core platform properties rather than add-ons: agents run where the customer's data lives (cloud, on-prem or edge), with policy enforcement, immutable audit trails and a judgment layer defining which decisions require human action. The company also markets a large library of pre-built vertical agents intended to reach production in weeks.

Technology

An agentic operating system (Trase Origin) that orchestrates, secures and governs AI agents across cloud, on-premises and edge devices, together with edge-deployed specialized language models. Stated capabilities include model-agnostic agent execution, unified policy enforcement, continuous monitoring, fully immutable audit trails, reinforcement learning from human feedback, a human-in-the-loop judgment layer, and HIPAA and SOC 2 compliance. A developer SDK (Trase Arena) supports custom agent construction.

Go-to-market

Direct enterprise sales supported by a marketplace of ready-to-deploy agents and a stated under-30-day time to production. The company is hiring enterprise and healthcare sales executives and sales engineers, and said it would use its June 2026 seed proceeds to expand its go-to-market team. It publishes customer-proof content (e.g., the Duke Health cardiology deployment) and is backed and promoted by Red Cell Partners.

Organizations in regulated, high-stakes sectors: health systems and clinical trial operators, defense and government teams, and regulated enterprises. Duke University Health System is a named customer.

Geography

Headquartered in McLean, Virginia, with hubs in Seattle and the Washington, D.C. metropolitan area; job postings list Seattle, McLean, Washington D.C. and US-remote locations. The 55-person team is described as distributed across the U.S.

History

Sources indicate Trase launched in the fall preceding its June 2026 funding announcement and began working with Duke University Health System after launch. It reported topping the GAIA leaderboard in September 2024 and a Hugging Face leaderboard in February 2025. Srirama Koneru was announced as Chief Technology Officer in November 2025. On June 24-25, 2026 the company announced a $107M seed round led by ARCH Venture Partners with participation from Red Cell Partners, reported by one outlet as bringing total funding to $117.5M.

Risks & controversies

Performance figures (99.8% administrative work reduction, $25M+ annualized value creation, and the Duke fax-routing results) are company-reported benchmarks or initial observations; the company states that peer-reviewed research on the Duke deployment is still upcoming. Reported total funding figures differ between sources and internal records.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Administrative work reduction (company benchmark across deployed workflows)Jan 202699.8%
Annual staff capacity unlocked at Duke Health cardiologyJun 2026$285.4K
Annualized value creation (company benchmark across deployed workflows)Jan 2026$25M
Compliance certificationsJun 2026HIPAA and SOC 2 compliant
Duke Health fax triage speed vs. manual processingJun 20267.1 x faster
HeadcountJun 202655 employees
Monthly faxes processed at Duke Health cardiology clinicJun 20265,000 faxes/month
Open job postingsJan 20265 roles
Staff hours saved per month at Duke Health cardiologyJun 20261,395 hours/month
Time to production deployment (company-reported)Jan 2026Under 30 days
Total funding raised to dateJun 2026$117.5M

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Competitors Β· 3

by search overlap

Companies competing with Trase for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 5

launches, deals, and filings
Jun 2026
Trase raises $107M seed round led by ARCH Venture Partners

Trase announced a $107M seed round led by ARCH Venture Partners with participation from Red Cell Partners and others, to expand its go-to-market team and continue developing its Trase Origin operating system. One report dates the round June 24, 2026 and puts total funding at $117.5M.

$107M source β†—

Jun 2026
Deployment of Trase agents at Duke University Health System

Since its launch the prior fall, Trase has worked with Duke University Health System to deploy specialized agents in its Division of Cardiology, including a fax-routing agent handling more than 5,000 faxes per month, with additional agents deployed or ready for deployment for administrative workflows and chronic condition management.

source β†—

Nov 2025
Srirama Koneru joins Trase as Chief Technology Officer

Former AWS Bedrock general manager Srirama Koneru was announced as Chief Technology Officer, bringing engineering leadership experience from Amazon, Google and Salesforce.

source β†—

Feb 2025
Trase again tops Hugging Face leaderboard

Company blog reports Trase reclaimed the top spot on the Hugging Face leaderboard for general AI assistants.

source β†—

Sep 2024
Trase tops GAIA leaderboard for general AI assistants

Company blog reports Trase took the top spot on the GAIA leaderboard for general AI assistants, ahead of agents from Meta, Microsoft and Google.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Trase do?
Trase builds an agentic AI operating system with governance, auditability and data sovereignty for healthcare, government and regulated enterprises.
Who founded Trase?
Trase was founded by Joe Laws.
Who are Trase's investors?
Trase's investors include Quadri Ventures, ARCH Venture Partners.
How much funding has Trase raised?
Trase has disclosed $214M raised across 2 rounds.